Loading clinical trials...
Loading clinical trials...
An Expressive Writing Program to Support Emotional Wellness Among Young Adults With Hematologic Malignancy
The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness. Participants will * Take part in an online expressive writing workshop for four weeks * Take three surveys at different times over 12 weeks Researchers will compare changes in mental wellness reported by the participants of the workshop to those who will wait four weeks to start the workshop. After four weeks, the participants who are waiting will start their workshop.
The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness. Participants will * Take part in an online expressive writing workshop for four weeks * Take three surveys at different times over 12 weeks Participants will be randomly assigned to one of two study groups by chance. Group 1 will start the workshop the following week. Group 2 will wait 4 weeks before starting the workshop. The workshop is the same for both groups. Each week, participants will be given a writing prompt and asked to spend at least 15 minutes writing a response. They will be able to share their writing response in a private online community group if they would like, but sharing is not required. Researchers will then compare changes in mental wellness between group 1 and 2.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Blood Cancer United
Washington D.C., District of Columbia, United States
Start Date
February 1, 2026
Primary Completion Date
September 30, 2026
Completion Date
September 30, 2026
Last Updated
February 17, 2026
100
ESTIMATED participants
Expressive Writing Workshop
BEHAVIORAL
Lead Sponsor
Blood Cancer United
NCT05529069
NCT07257419
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions